Seeking Alpha

Monsanto Company (MON)

  • May 23, 2013, 8:11 AM
    BASF (BASFY.PK) and Monsanto (MON) plan to commercially launch a drought-tolerant variety of genetically modified corn in the U.S. next year, a senior BASF official says. The two companies have a revenue sharing arrangement, with 60% of revenue going to MON and the rest to BASF.
    | Comment!
  • May 15, 2013, 2:38 PM
    Monsanto (MON +1%) CEO Hugh Grant is "not overly concerned" by the USDA's decision to compile fuller environmental assessments of MON's new soybean and cotton seeds, remarks which differ with industry complaints about the "burdensome" U.S. regulatory system. But Grant has little patience for opponents of genetically modified foods; they're guilty of "elitism” and fail to consider needs of the global population.
  • May 15, 2013, 9:30 AM
    Julian Robertson's Tiger Management unloaded the 42K Apple (AAPL) shares the firm still had going into Q1. Tiger, which has owned Apple for years, had pared its stake from 101K in Q4. On the other hand, Tiger initiated positions in Dunkin' Brands (DNKN - 546K shares), Monsanto (MON - 192K), McGraw Hill (MHP - 408K), and H&R Block (HRB - 849K). AAPL -1.1%. (13F) (Q4 hedge fund sales)
  • May 15, 2013, 8:59 AM
    Monsanto (MON) says it is pushing ahead with plans to introduce a controversial new type of herbicide-tolerant crop, unswayed by last week's decision by the U.S. government to extend its scrutiny of the proposed new crops. In fact, MON will try to take advantage of the regulatory delays by using the extra time to expose farmers and retailers to the product.
  • May 14, 2013, 10:24 AM
    U.S. taxpayers are footing the bill for overseas lobbying that promotes controversial biotech crops developed by Monsanto (MON), according to a report issued by Food & Water Watch. A review of hundreds of diplomatic cables to and from the State Department and embassies in more than 100 countries found officials actively promoting the commercialization of specific biotech seeds.
  • May 13, 2013, 6:20 PM
    Today's Supreme Court ruling in favor of Monsanto (MON) in a patent case appears to shut down future claims by farmers that patented seeds are a self-replicating product - Justice Kagan found the "blame-the-bean" defense tough to credit - but the decision might not apply to biotech or other industries, as "such inventions are becoming ever more prevalent, complex and diverse."
    | Comment!
  • May 13, 2013, 10:28 AM
    The U.S. Supreme Court rules in favor of Monsanto (MON -0.5%) in a patent infringement case involving a farmer who essentially made copies of MON's Roundup resistant soybeans by obtaining some from a grain elevator and using them to replant his crop. The court's decision was unanimous.
    | 1 Comment
  • May 10, 2013, 1:12 PM
    The USDA will conduct environmental assessments of new corn, soybean and cotton seeds genetically engineered to withstand herbicides, further delaying the possible launch of products from Monsanto (MON) and Dow Chemical (DOW). DOW had hoped to sell 2,4-D-tolerant corn to farmers for the 2013 growing season, as well as 2,4-D-tolerant soybeans; MON has developed dicamba-tolerant soybeans and cotton.
    | 1 Comment
  • Apr. 11, 2013, 9:18 AM
    Monsanto (MON) and Dow Chemical (DOW) reach new cross-licensing agreements for creation of the next generation of advanced weed and insect control technology in corn. MON will license DOW's new Enlist Weed Control System herbicide-tolerant trait for use in field corn, and Dow will license MON's new corn rootworm technology. Financial terms are not disclosed.
  • Apr. 3, 2013, 2:16 PM
    From Monsanto's (MON +0.3%) conference call: If MON achieves the higher profit it is targeting, it will mark the third straight year of better than 20% EPS growth, Chairman Hugh Grant says. But the market reaction is only mildly enthusiastic since gains that beat analysts' expectations stemmed not from seed sales but from the smaller glyphosate herbicide business, and from a lower tax rate.
    | Comment!
  • Apr. 3, 2013, 8:28 AM
    More on Monsanto's (MON) FQ2 results: Raises FY 2013 EPS guidance to $4.40-$4.50 vs. $4.54 consensus and prior guidance of $4.30-$4.40. Net sales rose 15% to $5.5B, driven by a 16% increase in sales from its global corn business. Sales in seeds and genomics totaled $4.3B, $422M more than the same period last year. Shares +1% premarket.
  • Apr. 3, 2013, 8:03 AM
    Monsanto (MON): FQ2 EPS of $2.73 beats by $0.17. Revenue of $5.47B beats by $0.18B. (PR)
    | 1 Comment
  • Apr. 3, 2013, 12:05 AM
    Notable earnings before Wednesday’s open: CAG, MON, SCHN
    | Comment!
  • Apr. 2, 2013, 5:30 PM
    Notable earnings before Wednesday’s open: CAG, MON, SCHN
    | Comment!
  • Mar. 26, 2013, 12:21 PM
    Shares of Monsanto (MON +3.7%) and DuPont (DD -1%) react differently to news the companies settled a patent dispute over technology rights for genetically modified seeds. The deal tosses out a $1B jury verdict DD was ordered to pay MON last year; instead, DD will make at least $1.75B in royalty payments over several years in return for broad access to develop products using MON's genetic technology.
    | Comment!
  • Mar. 15, 2013, 7:05 PM
    Morgan Stanley selects 20 stocks for the long term, based on "competitive advantages, business model, pricing power, cost efficiency and growth": AMZN, AMT, BLK, CPN, CP, CVX, COST, EL, GILD, HON, JPM, LTD, MON, NWSA, PM, RPM, SBUX, SYMC, TMO, WMB.
Visit Seeking Alpha's
MON vs. ETF Alternatives
Company Description
Monsanto Co is a provider of agricultural products for farmers. The Company offers corn, soybean, cotton, wheat, canola, sorghum and sugar cane seeds. Its segments are Seeds and Genomics and Agricultural Productivity.